Allergan gets thumbs up from Icahn, CEO says
June 06, 2016 at 13:38 PM EDT
Allergan CEO Brent Saunders tells CNBC's "Squawk on the Street" why attention from famed activist investor Carl Icahn's is a stamp of approval.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.